Diagnosis of influenza in the community: Relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza

Archives of Internal Medicine

Volumn 161, Issue 17, 2001, Pages 2116-2122

  Zambon, Maria ^a   Hays, John ^a   Webster, Alison ^b   Newman, Robert ^c   Keene, Oliver ^b  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ZANAMIVIR;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIROLOGY; VIRUS DETECTION; VIRUS ISOLATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; COMMUNITY-ACQUIRED INFECTIONS; DOUBLE-BLIND METHOD; FEMALE; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PYRANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALIC ACIDS; VIRUS CULTIVATION; ZANAMIVIR;

EID: 0035944362     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.17.2116     Document Type: Article

References (25)

1. Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. Oxford, England: Blackwell Science; 1998;19:219-264.
2. Fleming DM, Cross KW. Respiratory syncytial virus or influenza? Lancet. 1993;342:1507-1510.
3. Ellis JS, Fleming DM, Zambon MC. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol. 1997;35:2076-2082.
4. Stockton J, Ellis JS, Saville M, Clewley JP, Zambon MC. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol. 1998;36:2990-2995.
5. von Itzstein M, Wu WY, Kok GB, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993;363:418-423.
6. Makela MJ, Pauksens K, Rostila T, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect. 2000;40:42-48.
7. Lalezari J, Klein T, Stapleton J, Elliott M, Flack N, Keene O. The efficacy and safety of inhaled zanamivir in the treatment of influenza in otherwise healthy and "high risk" individuals in North America [abstract]. J Antimicrob Chemother. 1999;44 (A):42.
8. Newman RW, Jennings R, Major DL, et al. Immune responses of human volunteers and anmials to vaccination with egg-grown influenza A (H1N1) virus is influenza by three amino acid substitutions in the haemagglutinin molecule. Vaccine. 1999;11:400-406.
9. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet. 1998;352:1877-1881.
10. Nicholson KG, Aoki FY, Osterhuas AD, et al, for the Neuramindase Inhibitor Flu Treatment Investigator Group. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet. 2000;355:1845-1850.
11. Treanor JJ, Hayden FG, Vrooman PS, et al, for the US Oral Neuraminidase Study Group. Efficacy and safety of oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA. 2000;283:1016-1024.
12. Hayden FG, Osterhaus A, Treanor JJ, et al, for the GG167 Influenza Study Group. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med. 1997;337:874-879.
13. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243-3247.
14. Pregliasco F, Mensi C, Camorali L, Anselmi G. Comparison of RT-PCR with other diagnostic assays for rapid detection of influenza viruses. J Med Virol. 1998;56:168-173.
15. Carman WF, Wallace LA, Walker J, et al. Rapid virological surveillance of community influenza infection in general practice. BMJ. 2000;321:736-737.
16. Schweiger B, Zadow I, Heckler R, Timm H, Pauli G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples J Clin Microbiol. 2000;38:1552-1558.
17. Magnard C, Valette M, Aymard M, Lina B. Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses. J Med Virol. 1999;59:215-220.
18. Webster A, Boyce M, Edmundsson S, Miller I. Coadministration of orally inhaled zanamivir with inactivated trivalent vaccine does not adversely affect the production of antihaemagglutinin antibodies in the serum of healthy volunteers. Clin Pharmacokinet. 1999;36(suppl 11):51-58.
19. Douglas RG. Influenza in man. In: Kilbourne ED, ed. Influenza Viruses and Influenza. New York, NY: Academic Press Inc; 1975:395.
20. Zambon M. Laboratory diagnosis of influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. Oxford, England: Blackwell Science; 1998;19:219-264.
21. Kaiser L, Briones MS, Hayden FG. Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. J Clin Virol. 1999;14:191-197.
22. Covalciuc KA, Webb KH, Carlson CA. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (Flu OIA Test) and culture methods. J Clin Microbiol. 1999;37:3971-3974.
23. Frank AL, Taber LH, Wells JM. Comparison of infection rates and severity of illness for influenza A subtypes H1N1 and H3N2. J Infect Dis. 1985;151:73-80.
24. Monto AS, Koopman JS, Longini IM Jr. Tecumseh study of illness, XIII: influenza infection and disease, 1976-1981. Am J Epidemiol. 1985;121:811-822.
25. Gardner P, Schaffner W. Immunization of adults [review]. N Engl J Med. 1993;328:1252-1258.